BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23419719)

  • 21. The SETD8/PR-Set7 Methyltransferase Functions as a Barrier to Prevent Senescence-Associated Metabolic Remodeling.
    Tanaka H; Takebayashi SI; Sakamoto A; Igata T; Nakatsu Y; Saitoh N; Hino S; Nakao M
    Cell Rep; 2017 Feb; 18(9):2148-2161. PubMed ID: 28249161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone methyltransferase KMT5A gene modulates oncogenesis and lipid metabolism of papillary thyroid cancer in vitro.
    Liao T; Wang YJ; Hu JQ; Wang Y; Han LT; Ma B; Shi RL; Qu N; Wei WJ; Guan Q; Xiang J; Chen JY; Sun GH; Li DS; Mu XM; Ji QH
    Oncol Rep; 2018 May; 39(5):2185-2192. PubMed ID: 29512765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Product specificity and mechanism of protein lysine methyltransferases: insights from the histone lysine methyltransferase SET8.
    Zhang X; Bruice TC
    Biochemistry; 2008 Jun; 47(25):6671-7. PubMed ID: 18512960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase.
    Couture JF; Collazo E; Brunzelle JS; Trievel RC
    Genes Dev; 2005 Jun; 19(12):1455-65. PubMed ID: 15933070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of the methylation of Numb by the SET8 protein lysine methyltransferase.
    Weirich S; Kusevic D; Kudithipudi S; Jeltsch A
    Sci Rep; 2015 Sep; 5():13813. PubMed ID: 26391684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SET8 plays a role in controlling G1/S transition by blocking lysine acetylation in histone through binding to H4 N-terminal tail.
    Yin Y; Yu VC; Zhu G; Chang DC
    Cell Cycle; 2008 May; 7(10):1423-32. PubMed ID: 18418072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new regulator of the cell cycle: the PR-Set7 histone methyltransferase.
    Wu S; Rice JC
    Cell Cycle; 2011 Jan; 10(1):68-72. PubMed ID: 21200139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis of nucleosomal H4K20 methylation by methyltransferase SET8.
    Shi L; Huang L; Long H; Song A; Zhou Z
    FASEB J; 2022 Jun; 36(6):e22338. PubMed ID: 35532550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic methylation of Numb by Set8 regulates its binding to p53 and apoptosis.
    Dhami GK; Liu H; Galka M; Voss C; Wei R; Muranko K; Kaneko T; Cregan SP; Li L; Li SS
    Mol Cell; 2013 May; 50(4):565-76. PubMed ID: 23706821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small-molecule inhibitors of SETD8 with cellular activity.
    Blum G; Ibáñez G; Rao X; Shum D; Radu C; Djaballah H; Rice JC; Luo M
    ACS Chem Biol; 2014 Nov; 9(11):2471-8. PubMed ID: 25137013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The histone H4 lysine 20 monomethyl mark, set by PR-Set7 and stabilized by L(3)mbt, is necessary for proper interphase chromatin organization.
    Sakaguchi A; Joyce E; Aoki T; Schedl P; Steward R
    PLoS One; 2012; 7(9):e45321. PubMed ID: 23024815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of p53 function by SET8-mediated methylation at lysine 382.
    Shi X; Kachirskaia I; Yamaguchi H; West LE; Wen H; Wang EW; Dutta S; Appella E; Gozani O
    Mol Cell; 2007 Aug; 27(4):636-46. PubMed ID: 17707234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis of nucleosomal histone H4 lysine 20 methylation by SET8 methyltransferase.
    Ho CH; Takizawa Y; Kobayashi W; Arimura Y; Kimura H; Kurumizaka H
    Life Sci Alliance; 2021 Apr; 4(4):. PubMed ID: 33574035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The SET8 H4K20 protein lysine methyltransferase has a long recognition sequence covering seven amino acid residues.
    Kudithipudi S; Dhayalan A; Kebede AF; Jeltsch A
    Biochimie; 2012 Nov; 94(11):2212-8. PubMed ID: 22583696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone lysine methyltransferase SET8 is a novel therapeutic target for cancer treatment.
    Yang C; Wang K; Zhou Y; Zhang SL
    Drug Discov Today; 2021 Oct; 26(10):2423-2430. PubMed ID: 34022460
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Crain AT; Butler MB; Hill CA; Huynh M; McGinty RK; Duronio RJ
    bioRxiv; 2024 Mar; ():. PubMed ID: 38559189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone Methyltransferase SET8 Epigenetically Reprograms Host Immune Responses to Assist Mycobacterial Survival.
    Singh V; Prakhar P; Rajmani RS; Mahadik K; Borbora SM; Balaji KN
    J Infect Dis; 2017 Aug; 216(4):477-488. PubMed ID: 28931237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SET8 induces epithelial‑mesenchymal transition and enhances prostate cancer cell metastasis by cooperating with ZEB1.
    Hou L; Li Q; Yu Y; Li M; Zhang D
    Mol Med Rep; 2016 Feb; 13(2):1681-8. PubMed ID: 26717907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SET8 expression is associated with overall survival in gastric cancer.
    Shi XL; Guo ZJ; Wang XL; Liu XL; Shi GF
    Genet Mol Res; 2015 Dec; 14(4):15609-15. PubMed ID: 26634528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. microRNA-7 suppresses the invasive potential of breast cancer cells and sensitizes cells to DNA damages by targeting histone methyltransferase SET8.
    Yu N; Huangyang P; Yang X; Han X; Yan R; Jia H; Shang Y; Sun L
    J Biol Chem; 2013 Jul; 288(27):19633-42. PubMed ID: 23720754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.